Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 2.6/5
111 Inc (YI US)
Watchlist
Contact IR
123
Analysis
Information Technology
•
China
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription, and other services. 111 serves patients in China.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
111 Inc
•
25 Mar 2025 21:27
•
Issuer-paid
111, Inc. - Positioned to Leverage Market Turnaround When It Comes
Seven years after launching its B2B operations, 111 delivered its first annual operational profit and positive operating cash flow.
Water Tower Research
Follow
180 Views
Share
bullish
•
111 Inc
•
03 Dec 2024 00:07
•
Issuer-paid
111, Inc. - YI: Resilience Amid Short-Term Challenges
Persistently weak consumer sentiment (see Figure 1), combined with the impact of increased regulatory oversight in the healthcare system
Water Tower Research
Follow
227 Views
Share
bullish
•
111 Inc
•
11 Oct 2024 23:33
•
Issuer-paid
111, Inc. - Continuing to Build Up a Robust and Nimble Warehousing & Distribution Network
Two fulfillment centers added. In line with its goal to establish a national pharmaceutical logistics network (Kunpeng), 111 announced that it has...
Water Tower Research
Follow
463 Views
Share
bullish
•
Lufax Holding
•
20 Mar 2024 23:12
•
Syndicated
Quick Ideas #9
A Chinese lending company, lending out directly and providing a peer to peer lending platform for the Chinese market. With Ping An being a ~41%...
Turtles all the way down
Follow
434 Views
Share
bullish
•
Nameson Holdings
•
06 Mar 2024 23:55
•
Syndicated
Some Updates #2
First a new holding, Nameson Holdings (HKG:1982). A vertically integrated knitwear and fabrics manufacturer with most of its production base in...
Turtles all the way down
Follow
335 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.54.8
x